VerAvanti

Innovating intravascular imaging with advanced single-use endoscopes for enhanced patient care. Innovating intravascular imaging with advanced single-use endoscopes for enhanced patient care. They are dedicated to transforming medical diagnostics and treatment through precision and innovation. Their patented Scanning Fiber Endoscope (SFE) technology aims to enhance accuracy, safety, and efficiency in intravascular procedures. The company focuses on addressing sightline gaps in cardiology, neurosurgery, and peripheral artery work, enabling more proactive diagnosis. The company operates in the HealthTech > Disease Self Management, HealthTech > Healthcare IT sector. Founded in 2012 and headquartered in Redmond, United States and has raised $38.9 million in Series B funding. Key investors include HHS.

Wearable Technology > Health and Wellness Devices > Cardiac,

Disease Self Management > Cardiac and Vascular Disorders > Monitoring > Heart Health,

Healthcare IT > Provider > Clinical Operations > Decision Support > Suite Solutions > Cardiology,

Cardiac and Vascular Disorders > Medical Devices > Screening Devices > Cardiac Diagnostic